UBS Group’s NeueHealth NEUE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $218K | Sell |
31,612
-5,113
| -14% | -$35.3K | ﹤0.01% | 5424 |
|
2025
Q1 | $248K | Sell |
36,725
-3,814
| -9% | -$25.8K | ﹤0.01% | 5159 |
|
2024
Q4 | $301K | Buy |
40,539
+36,753
| +971% | +$273K | ﹤0.01% | 5019 |
|
2024
Q3 | $19.8K | Buy |
3,786
+2,224
| +142% | +$11.6K | ﹤0.01% | 6174 |
|
2024
Q2 | $8.5K | Buy |
1,562
+1,498
| +2,341% | +$8.15K | ﹤0.01% | 6642 |
|
2024
Q1 | $416 | Sell |
64
-259
| -80% | -$1.68K | ﹤0.01% | 7400 |
|
2023
Q4 | $2.47K | Buy |
323
+132
| +69% | +$1.01K | ﹤0.01% | 6890 |
|
2023
Q3 | $1.14K | Buy |
191
+126
| +194% | +$752 | ﹤0.01% | 6933 |
|
2023
Q2 | $794 | Sell |
65
-770
| -92% | -$9.41K | ﹤0.01% | 7011 |
|
2023
Q1 | $14.7K | Buy |
835
+46
| +6% | +$809 | ﹤0.01% | 6236 |
|
2022
Q4 | $41K | Buy |
789
+505
| +178% | +$26.3K | ﹤0.01% | 5794 |
|
2022
Q3 | $24K | Sell |
284
-1,105
| -80% | -$93.4K | ﹤0.01% | 6072 |
|
2022
Q2 | $202K | Sell |
1,389
-7,523
| -84% | -$1.09M | ﹤0.01% | 3929 |
|
2022
Q1 | $1.38M | Buy |
8,912
+8,660
| +3,437% | +$1.34M | ﹤0.01% | 2961 |
|
2021
Q4 | $69K | Buy |
252
+48
| +24% | +$13.1K | ﹤0.01% | 5553 |
|
2021
Q3 | $133K | Buy |
204
+199
| +3,980% | +$130K | ﹤0.01% | 4563 |
|
2021
Q2 | $7K | Buy |
+5
| New | +$7K | ﹤0.01% | 7252 |
|